ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Arbutus Biopharma Corporation

Arbutus Biopharma Corporation (ABUS)

3,205
-0,005
(-0,16%)
Fermé 21 Décembre 10:00PM
3,21
0,005
(0,16%)
Après les heures de négociation: 12:55AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
3,205
Prix Achat
3,21
Prix Vente
3,35
Volume échangé
2 819 877
3,16 Fourchette du Jour 3,26
2,199 Plage de 52 semaines 4,725
Cap du marché
Clôture Veille
3,21
Ouverture
3,18
Dernière Transaction
2
@
3.21
Dernière heure de transaction
Volume financier
US$ 9 069 298
VWAP
3,2162
Volume moyen (3 m)
840 631
Actions en circulation
189 491 685
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-8,32
Bénéfice par action (BPA)
-0,38
Chiffre d'affairess
18,14M
Bénéfice net
-72,85M

À propos de Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Burnaby, British Columbia, Can
Fondé
-
Arbutus Biopharma Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ABUS. Le dernier cours de clôture d'Arbutus Biopharma était de US$3,21. Au cours de la dernière année, les actions de Arbutus Biopharma ont été négociées dans une fourchette de prix de US$ 2,199 à US$ 4,725.

Arbutus Biopharma compte actuellement 189 491 685 actions en circulation. La capitalisation boursière d'Arbutus Biopharma est de US$608,27 million. Arbutus Biopharma a un ratio cours/bénéfice (ratio PE) de -8.32.

Flux d'options Arbutus Biopharma (ABUS)

Flux global

Baissier

Prime nette

-80k

Calls / Puts

50,00%

Ach. / Vent.

200,00%

OTM / ITM

50,00%

Sweeps Ratio

0,00%

ABUS Dernières nouvelles

Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors

Believes Now Is the Logical Time for Arbutus to Pursue a License and Collaboration Agreement With a Strategic Partner and Explore All Options for HBV Portfolio Urges Arbutus to Commit to No...

Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat

WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...

Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon

50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved...

Arbutus to Present at Jefferies London Healthcare Conference

WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.335-9.463276836163.543.6053.138089683.36206752CS
4-0.265-7.636887608073.473.793.137878853.50021781CS
12-0.755-19.06565656573.964.34913.138406313.74911844CS
260.2056.8333333333334.7252.9159979943.81308085CS
520.99545.02262443442.214.7252.19910546223.30927301CS
156-0.965-23.14148681064.174.7251.6910930802.91167976CS
2600.95542.44444444442.2590.8821329443.71865873CS

ABUS - Frequently Asked Questions (FAQ)

What is the current Arbutus Biopharma share price?
The current share price of Arbutus Biopharma is US$ 3,205
How many Arbutus Biopharma shares are in issue?
Arbutus Biopharma has 189 491 685 shares in issue
What is the market cap of Arbutus Biopharma?
The market capitalisation of Arbutus Biopharma is USD 608,27M
What is the 1 year trading range for Arbutus Biopharma share price?
Arbutus Biopharma has traded in the range of US$ 2,199 to US$ 4,725 during the past year
What is the PE ratio of Arbutus Biopharma?
The price to earnings ratio of Arbutus Biopharma is -8,32
What is the cash to sales ratio of Arbutus Biopharma?
The cash to sales ratio of Arbutus Biopharma is 33,44
What is the reporting currency for Arbutus Biopharma?
Arbutus Biopharma reports financial results in USD
What is the latest annual turnover for Arbutus Biopharma?
The latest annual turnover of Arbutus Biopharma is USD 18,14M
What is the latest annual profit for Arbutus Biopharma?
The latest annual profit of Arbutus Biopharma is USD -72,85M
What is the registered address of Arbutus Biopharma?
The registered address for Arbutus Biopharma is 100, 8900 GLENLYON PARKWAY, GLENLYON BUSINESS PARK, BURNABY, BRITISH COLUMBIA, V5J 5J8
What is the Arbutus Biopharma website address?
The website address for Arbutus Biopharma is www.tekmirapharm.com
Which industry sector does Arbutus Biopharma operate in?
Arbutus Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock